Friulchem S.p.A. FCM.MI Stock
Friulchem S.p.A. Price Chart
Friulchem S.p.A. FCM.MI Financial and Trading Overview
Friulchem S.p.A. stock price | 0.95 EUR |
Previous Close | 1.05 EUR |
Open | 1.05 EUR |
Bid | 1.01 EUR x N/A |
Ask | 1.09 EUR x N/A |
Day's Range | 1.05 - 1.05 EUR |
52 Week Range | 0.96 - 1.23 EUR |
Volume | 1.5K EUR |
Avg. Volume | 4.77K EUR |
Market Cap | 6.3M EUR |
Beta (5Y Monthly) | 0.580424 |
PE Ratio (TTM) | Infinity |
EPS (TTM) | -0.05 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.5 EUR |
FCM.MI Valuation Measures
Enterprise Value | N/A |
Trailing P/E | Infinity |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.17650516 |
Price/Book (mrq) | 0.5969301 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Friulchem S.p.A. Stock Price History
Beta (5Y Monthly) | 0.580424 |
52-Week Change | 1.94% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.23 EUR |
52 Week Low | 0.96 EUR |
50-Day Moving Average | 1.07 EUR |
200-Day Moving Average | 1.08 EUR |
FCM.MI Share Statistics
Avg. Volume (3 month) | 4.77K EUR |
Avg. Daily Volume (10-Days) | 6.6K EUR |
Shares Outstanding | 6M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 2.14% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0.091% |
Operating Margin (ttm) | 1.43% |
Gross Margin | 17.98% |
EBITDA Margin | 4.48% |
Management Effectiveness
Return on Assets (ttm) | 0.90% |
Return on Equity (ttm) | 0.065% |
Income Statement
Revenue (ttm) | 35.69M EUR |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 26.90% |
Gross Profit (ttm) | 5.9M EUR |
EBITDA | 1.6M EUR |
Net Income Avi to Common (ttm) | 33K EUR |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | -64.099% |
Balance Sheet
Total Cash (mrq) | 7.11M EUR |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | 12.56M EUR |
Total Debt/Equity (mrq) | 115.74 EUR |
Current Ratio (mrq) | 1.436 |
Book Value Per Share (mrq) | 1.759 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Friulchem S.p.A.
Country | Italy |
State | MI |
City | Milan |
Address | Via Carlo Ravizza 40 |
ZIP | 20149 |
Phone | 39 0236 59 14 50 |
Website | https://www.friulchem.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Friulchem S.p.A. engages in the research, development, and production of original and generic pharmaceutical products for human and veterinary fields in Italy. It offers generic cosmoceuticals and food supplements; chewable cubes for animals; and cosmetic products for pigmentation disorders. The company is based in Milan, Italy.
Q&A For Friulchem S.p.A. Stock
What is a current FCM.MI stock price?
Friulchem S.p.A. FCM.MI stock price today per share is 0.95 EUR.
How to purchase Friulchem S.p.A. stock?
You can buy FCM.MI shares on the Milan exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Friulchem S.p.A.?
The stock symbol or ticker of Friulchem S.p.A. is FCM.MI.
Which industry does the Friulchem S.p.A. company belong to?
The Friulchem S.p.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Friulchem S.p.A. have in circulation?
The max supply of Friulchem S.p.A. shares is 6M.
What is Friulchem S.p.A. Price to Earnings Ratio (PE Ratio)?
Friulchem S.p.A. PE Ratio is now.
What was Friulchem S.p.A. earnings per share over the trailing 12 months (TTM)?
Friulchem S.p.A. EPS is -0.05 EUR over the trailing 12 months.
Which sector does the Friulchem S.p.A. company belong to?
The Friulchem S.p.A. sector is Healthcare.